Vulnerability · Published Apr 4, 2023 · Assigned by mitre
CVE-2022-48226
High 8.4
In plain English
A high-severity privilege mismanagement in the affected software. There are no confirmed reports of exploitation so far. The chance it is exploited in the next 30 days is estimated at 0.2% (higher than 8% of all known vulnerabilities).
Severity (CVSS 3.1)8.4High
Exploit odds (30 days)0.2%top 92.1% of all CVEs
Exploited in the wildNo reportsCISA SSVC: none
Attack toolingNoneno public tooling known
Official description
An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During installation, an EXE gets executed out of C:\Windows\Temp. A standard user can create the path file ahead of time and obtain elevated code execution. Permissions need to be modified to prevent manipulation.
Affected products (as reported)
Weakness: CWE-269 · Vector: CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H